Health Management

A study of Medicaid and Medicare Advantage plan members shows that addressing social determinants of health is important not only to reduce health spending, but also to improve patient outcomes.

Treating patients with cancer is often challenging yet rewarding work. But caring for patients in an urban setting, where some patients don’t speak English and other patients aren’t fully insured and possibly facing significant financial challenges.

Can you identify the latest developments related to the treatment of blood cancers? Test your knowledge.

Here’s how community oncologists seize opportunities to improve the quality of care and create performance metrics.

Analysis from Avalere shows why healthcare execs should understand how oncology practices are evolving in response to the OCM.

A Canadian study has exciting findings about offspring exposed to tumor necrosis factors.

Experts say Anthem’s acquisition of Aspire Health, the nation’s biggest non-hospice, community-based palliative care provider, continues the health insurer race to dominate this kind of health experience.

A network of value-based care programs from the Blue Cross Blue Shield Association emphasizes quality instead of quantity of medical services provided.

Major depression diagnoses have risen, according to a study of medical claims by the Blue Cross Blue Shield Association. Find out which populations suffer the most.

Two studies from the University of Minnesota’s School of Public Health has interesting findings about primary care among low-income patients enrolled in a Medicaid ACO.

A new study explored racial/ethnic differences in healthcare outcomes among patients receiving home healthcare. Here are the shocking results.

The new Bipartisan Budget Act of 2018 (to be in effect on January 2019) institute new reimbursement guidelines for biosimilars under the Medicare coverage gap discount program that remove disincentives for biosimilar uptake and level the playing field for the future market place.

Here's how artificial intelligence improves the healthcare ecosystem.

Experts say this new migraine medication, the first in 50 years, shows great promise. Here’s what you need to know, including the cost implications

A new study sheds light on PDMPs and their effectiveness in tackling the opioid crisis and includes one disturbing finding you won’t believe.

Jill Feldstein, MPA, chief operating officer for the Penn Center for Community Health Workers, tells Managed Healthcare Executive how the organization improves population health and provides social support, advocacy, and navigation to high-risk patients.

A new survey by Black Book Research found the top requested services from patients are available through EHRs.

A new study says that physicians and nurses might be overlooking these alerts-a move that risks putting patients in danger.

A new study has shocking results about which commercially available apps improve diabetes-related outcomes.

A new study investigates the impact of interruptions in the emergency room. Here are the disturbing results

The latest research from PwC’s Health Research Institute has shown that U.S. health leaders are making building a better customer experience for patients a top priority instead of a “nice to have.”

Unique trends are occurring in the pharmaceutical pipeline that would have been unheard of just five years ago.

A new study has surprising findings about the cost effectiveness of continuous glucose monitoring for type 1 diabetes patients.

To build trust, health insurers need to demonstrate their value to customers. That means offering a convenient, satisfying customer experience. Here’s how.

This type of focused approach incorporates four key steps.